Company Filing History:
1 out of 484 
1 out of 2,340 
Years Active: 2014
Title: Innovations by Inventor Hongbin Yuan
Introduction
Hongbin Yuan is a notable inventor based in San Diego, California. He has made significant contributions to the field of medical research, particularly in the development of isoform-selective HDAC inhibitors. His work has implications for cancer treatment, neurological diseases, and malaria.
Latest Patents
Hongbin Yuan holds a patent for isoform-selective HDAC inhibitors. This invention relates to methods of sensitizing cancer cells to the cytotoxic effects of radiotherapy. Additionally, it provides methods for treating cancer, neurological diseases, and malaria. The invention also includes pharmaceutical compositions comprising an HDAC inhibitor and kits that utilize this innovative compound.
Career Highlights
Throughout his career, Hongbin Yuan has worked with prestigious institutions such as Georgetown University and the University of Illinois. His research has been pivotal in advancing therapeutic strategies in oncology and other medical fields.
Collaborations
Some of his notable coworkers include Alan P. Kozikowski and Mira Jung. Their collaborative efforts have contributed to the success of various research projects and innovations.
Conclusion
Hongbin Yuan's work exemplifies the impact of innovative research in medicine. His contributions to the development of HDAC inhibitors are paving the way for new treatment options in cancer and other diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.